Exercise training program improves cardiorespiratory fitness in adults with chronic kidney disease – Medical Xpress

Click here to sign in with or
Forget Password?
Learn more
share this!
1
3
Share
Email
August 8, 2022
by National Kidney Foundation
A randomized trial recently published in the American Journal of Kidney Diseases (AJKD) found that a 12-month program of in-center aerobic and resistance exercise program improved physical functioning among adults 55 years and older with CKD stages G3b-4 and a high level of medical comorbidities.

Among adults ≥55 years with CKD stages G3b-4 and with a high level of comorbidity, a 12-month program of in-center aerobic and resistance exercise training was safe and feasible, and compared to health education control was associated with improvements in submaximal gait and mobility, as quantified by validated objective measure of physical performance. The exercise program also improved measured aerobic exercise capacity after 6 months compared to the health education group, although this difference was not sustained at 12 months.
In contrast, there was no impact on secondary outcomes of cardiovascular risk, including blood pressure, lipids, kidney function, and body mass index when compared to health education control. The latter finding may be explained by insufficient statistical power, a true absence of effect of the exercise training program on these risk factors, or (for blood pressure and glycemia) post-randomization changes in medical therapy. Compared to trials of similar interventions, adherence to the thrice weekly exercise regimen was moderately high, especially for the initial 6-month intervention period, though with a decline for the second 6-month period despite the option for at-home exercise once weekly.
In contrast to many prior exercise studies in CKD patients, this trial included an active comparator group, which provided similar (albeit less intensive) group social interaction to that experienced by participants in the supervised exercise training. Therefore, the observed differences in physical function are more likely to represent true physiologic effects of exercise training and are less likely to be explained by greater motivation among the exercise group from greater interactions with healthcare providers and other patients.
Furthermore, the exercise intensity goal was individualized for each subject, as a fixed range of each participant’s heart rate reserve. This accounted for inter-individual differences in maximal heart rate due to factors such as chronotropic incompetence and pharmacological beta-blockade. Study participants received 12 months of exercise training, testing the durability of the benefits of such interventions, in contrast to the 2-6 months of training in the majority of prior studies in kidney disease patients.
Finally, the study population included a racially diverse CKD population with a high burden of comorbidity including chronic cardiovascular diseases, reflective of the characteristics of many CKD patients in the U.S., thus enhancing the external validity of the study results.

Explore further
Facebook
Twitter
Email
Feedback to editors
16 hours ago
0
20 hours ago
0
Aug 16, 2022
0
Aug 16, 2022
0
Aug 16, 2022
1
1 hour ago
9 hours ago
9 hours ago
10 hours ago
10 hours ago
11 hours ago
11 hours ago
Apr 21, 2022
May 18, 2022
Sep 24, 2019
Jan 12, 2022
Aug 23, 2021
Aug 15, 2018
15 hours ago
14 hours ago
16 hours ago
11 hours ago
18 hours ago
13 hours ago
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
Daily science news on research developments and the latest scientific innovations
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.

source

Staff Editor

See author's posts